Tyrosine Kinase Inhibitors Improved Survival of Critically Ill EGFR-Mutant Lung Cancer Patients Undergoing Mechanical Ventilation
Journal
Biomedicines
Journal Volume
9
Journal Issue
10
Date Issued
2021-10-08
Author(s)
Abstract
Respiratory failure requiring mechanical ventilation is the major reason for lung cancer patients being admitted to the intensive care unit (ICU). Though molecular targeted therapies, especially epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs), have largely improved the survival of oncogene-driven lung cancer patients, few studies have focused on the performance of TKI in such settings.
Subjects
EGFR; critical care; lung cancer; mechanical ventilation; tyrosine kinase inhibitor
SDGs
Publisher
MDPI
Type
journal article